Patent · US Active

Amorphous onapristone compositions and methods of making the same

US10548905B2 · kind B2 · utility

0Cited by

21References

7Claims

0Family size

Assignee

CONTEXT BIOPHARMA, INC. · US

Inventors

Harry G. Brittain · Milford, US
Stefan Proniuk · Austin, US

Key dates

Filing date	Dec 13, 2016
Grant date	Feb 4, 2020
Priority date	—
Expiry date	Dec 13, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Amorphous forms of onapristone and methods of making such amorphous forms are provided. Amorphous forms can be characterized by their X-ray powder diffraction patterns and other properties.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.